# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-123442
Filing Date
2024-11-07
Accepted
2024-11-07 16:37:52
Documents
51
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | aclx-20240930.htm iXBRL | 10-Q | 1937920
2 | EX-31.1 | aclx-ex31_1.htm | EX-31.1 | 13831
3 | EX-31.2 | aclx-ex31_2.htm | EX-31.2 | 13834
4 | EX-32.1 | aclx-ex32_1.htm | EX-32.1 | 7967
5 | EX-32.2 | aclx-ex32_2.htm | EX-32.2 | 8193
| Complete submission text file | 0000950170-24-123442.txt |  | 5628916

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | aclx-20240930.xsd | EX-101.SCH | 810562
53 | EXTRACTED XBRL INSTANCE DOCUMENT | aclx-20240930_htm.xml | XML | 572027

Mailing Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065
Business Address 800 BRIDGE PARKWAY REDWOOD CITY CA 94065 240-327-0603
Arcellx, Inc. (Filer) CIK: 0001786205 (see all company filings)

EIN.: 472855917 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41259 | Film No.: 241436494
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)